Variability in CKD Stage in Outpatients Followed in Two Large Renal Clinics: Implications for CKD Trials and the Status of Current Knowledge of Patterns of CKD to ESRD Progression

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2011 Aug 31

PMID 21877120

Citations 4

Authors

Macaulay A Onuigbo

Nnonyelum T Onuigbo

Affiliations

Soon will be listed here.

Citing Articles

Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors".

Onuigbo M, Agbasi N World J Nephrol. 2014; 3(3):31-49.

PMID: 25332895 PMC: 4202491. DOI: 10.5527/wjn.v3.i3.31.

Effect of enhanced external counterpulsation treatment on renal function in cardiac patients.

Ruangkanchanasetr P, Mahanonda N, Raungratanaamporn O, Ruckpanich P, Kitiyakara C, Chaiprasert A BMC Nephrol. 2013; 14:193.

PMID: 24021027 PMC: 3847607. DOI: 10.1186/1471-2369-14-193.

Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.

Onuigbo M Nephron Extra. 2013; 3(1):36-49.

PMID: 23687511 PMC: 3656681. DOI: 10.1159/000351044.

Onuigbo M Open Med Inform J. 2012; 6:26-7.

PMID: 22934126 PMC: 3428784. DOI: 10.2174/1874431101206010026.

References

Onuigbo M, Onuigbo N . Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients. Int Urol Nephrol. 2008; 40(1):233-9. DOI: 10.1007/s11255-007-9299-2. View

Onuigbo M . Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD. Ren Fail. 2010; 32(8):954-8. DOI: 10.3109/0886022X.2010.502608. View

Sikaneta T, Abdolell M, Taskapan H, Roscoe J, Fung J, Nagai G . Variability in CKD stage in outpatients followed in two large renal clinics. Int Urol Nephrol. 2011; 44(5):1461-6. DOI: 10.1007/s11255-011-9934-9. View

Onuigbo M . The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2009; 25(4):1344-5. DOI: 10.1093/ndt/gfp678. View

Onuigbo M . Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?. Nephron Clin Pract. 2011; 118(4):c407-19. DOI: 10.1159/000324164. View